Chase Williams
Growth Equity Investor @ Goldman Sachs Growth Equity
New York, United States
Chase Williams is a Series B investor at Goldman Sachs Growth Equity in New York focused on Health Care and SaaS. Chase Williams is the Growth Equity Investor at Goldman Sachs. Chase Williams attended Colgate University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Chase Williams invests in
Stages Chase Williams invests in
Countries Chase Williams invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- SaaS 1 (25%)
- Finance 1 (25%)
- Medical 1 (25%)
- Privacy 1 (25%)
Stage
- Series B 2 (50%)
- Series C 2 (50%)
Country
- United States 3 (75%)
- Canada 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Fay
|
Fay is helping people eat better, and live better by connecting them with dietitians covered by their health insurance. | $50M / Series B / Feb 04, 2025 | |
H1.co
|
H1 is an AI-powered platform that helps identify and engage the right doctors for critical workflows across pharma, health plan, health system, and technology companies. At the core of the platform is H1’s Doctor Graph—a structured representation of physician identity, expertise, relationships, and behavioral signals, creating a powerful networkeffect as it is continuously enriched by participants across the healthcare ecosystem. Built on one of the world’s largest and most comprehensive global datasets of healthcare professionals, H1 combines deep healthcare data with agentic AI workflows to power critical workflows across drug development, medical and commercial engagement, care navigation, and provider data and network intelligence. Founded in 2017, the company is based in New York, United States. | $23M / Series C / Jun 09, 2022 | |
eVisit
|
Evisit is a web application that connects primary care providers with their patients by webcam or phone for the remote diagnosis and treatment of most minor medical conditions. The company is changing the healthcare delivery model and disrupting the $135 billion dollars primary care market by allowing physicians to recapture patient visits from theUrgent Care and Emergency Room. Physicians reclaim lost revenue from missed appointments, and patients receive high-quality care from work, home, or on the road from the doctor that knows them best.The eVisit platform allows providers to collect patient co-pays, electronically prescribe prescriptions to the pharmacy of the patients' choice, and submit medical charts for reimbursement to 3rd party payers. Unlike other telemedicine companies, eVisit circumvents many of the regulatory issues by maintaining the doctor-patient relationship and keeping patients in their PCMH (Patient-Centered Medical Home). | $45M / Series B / Sep 21, 2021 | |
Trulioo
|
Trulioo operates a Digital Identity Network that provides instant access to hundreds of procured, vetted, and trusted data sources around the world — all through a single integration. Deploying stringent security and privacy standards combined with the latest innovations in AI, biometrics, and cloud computing, Trulioo’s GlobalGateway solution hasaccess to information on more than 5 billion people and 250 million companies, enabling organizations to run identity verification checks with accuracy, reliability, speed, and scale. | $52.9M / Series C / Sep 17, 2019 |
Co-Investors
As part of the Merchant Banking Division of Goldman Sachs, GS Growth is the firm’s investment platform dedicated to providing preferred equity and mezzanine capital to high-growth companies.As of June 2019, Goldman Sachs' investing groups (Goldman Sachs Growth Equity, Principal Strategic Investments, and Private Capital Investing) havecombined to form the GS Growth team. The team targets investments of $20-250 million.
Goldman Sachs Growth Equity Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ashwin Gupta
Managing Director
|
|||
|
Cassidy Blonsky
Owner
|
|||
|
Chase Williams
Growth Equity Investor
|
|||
Kirk A. Lepke
Vice President
|
|||
Kirk A. Lepke
Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chase Williams invest in?
Chase Williams invests primarily in Health Care, SaaS and Finance startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chase Williams?
Public channels for Chase Williams include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Chase Williams last invest?
The most recent investment recorded for Chase Williams closed in Feb 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
